Shitara K, Matsuo K, Oze I, Mizota A, Kondo C, Nomura M, Yokota T, Takahari D, Ura T, Muro K.

Meta-analysis of neutropenia or leukopenia as a prognostic factor in patients with malignant disease undergoing chemotherapy.

Cancer Chemother Pharmacol.　2011 Aug;68(2):301-7. Epub 2010 Oct 20. Review.

Kanai M, Ishiguro H, Mori Y, Kitano T, Nishimura T, Matsumoto S, Yanagihara K, Chiba T, Toi M.

Temporary blood pressure drop after bevacizumab administration is associated with clinical course of advanced colorectal cancer

Br J Cancer. 105(11):1693-6, 2011.

Yokota T, Hatooka S, Ura T, Abe T, Takahari D, Shitara K, Nomura M, Kondo C, Mizota A, Yatabe Y, Shinoda M, Muro K.

Docetaxel plus 5-Fluorouracil and Cisplatin (DCF) Induction Chemotherapy for Locally Advanced Borderline-resectable T4 Esophageal Cancer.

Anticancer Res.　2011 Oct;31(10):3535-41.

Watanabe T, Tsuji Y, Kodama Y, Isoda H, Yamamoto H, Chiba T.

Relationship between serum angiopoietin-2 level and perfusion CT parameters in severe acute pancreatitis

Am J Gastroenterol. 106(10):1859-61.

Aoyagi K, Minashi K, H Igaki, Tachimori Y, Nisimura T, Hokamura N, Ashida A, Daiko H, Ochiai A, Muto M, Ohtsu A, Yoshida T, H Sasaki.

Artificially induced epithelail mesenchymal transition in surgical subjects: its implications in clinical and basic cancer research.

PLOS ONE. 21;6(4):2011

Matsuba H, Katada C, Masaki T, Nakayama M, Okamoto T, Hanaoka N, Tanabe S, Koizumi Wasaburo, Okamoto M, Muto M.

Diagnosis of the extent of advanced oropharyngeal and hypopharyngeal cancers by narrow band imaging with magnifying endoscopy.

The Laryngoscope.121(4):753-9:2011

Muto M, Morita S, Ezoe Y, Horimatsu T, Miyamoto S, Yoshii T, Iizuka T, Chiba T.

Macroscopic Estimation of Submucosal Invasion in the Esophagus.

Tec Gastrointest Endosc. 13(1);8-13: 2011

Matsubara J, Honda K, Ono M, Tanaka Y, Kobayashi M, Jung G, Yanagisawa K, Sakuma T, Nakamori S, Sata N, Nagai H, Ioka T, Okusaka T, Kosuge T, Tsuchida A, Shimahara M, Yasunami Y, Chiba T, Hirohashi S, Yamada T.

Reduced plasma level of CXC chemokine ligand 7 in patients with pancreatic cancer.

Cancer Epidemiol Biomarkers Prev. 2011; 20: 160-71.

Matsubara J, Shimada Y, Kato K, Nagai Y, Iwasa S, Nakajima TE, Hamaguchi T, Yamada Y, Takagi S, Kobayashi K, Yoshioka A, Nakayama N,Tsuji A:

Phase II study of bolus 5-fluorouracil and leucovorin combined with weekly paclitaxel (FLTAX) as first-line therapy for advanced gastric cancer.

Oncology 2011; 81: 291-297

Matsubara J, Honda K, Ono M, Sekine S, Tanaka Y, Kobayashi M, Jung G, Sakuma T, Nakamori S, Sata N, Nagai H, Ioka T, Okusaka T, Kosuge T,Tsuchida A, Shimahara M, Yasunami Y, Chiba T, Yamada T:

Identification of adipophilin as a potential plasma biomarker for colorectal cancer using label-free quantitative mass spectrometry and protein microarray.

Cancer Epidemiol Biomarkers Prev 2011; 20: 2195-2203.